Treatment with Peg-interferon α-2b for HBeAg-positive chronic hepatitis B: HBsAg loss is associated with HBV genotype

American Journal of Gastroenterology

Volumn 101, Issue 2, 2006, Pages 297-303

  Flink, Hajo J ^a   Van Zonneveld, Monika ^a   Hansen, Bettina E ^a   De Man, Robert A ^a   Schalm, Solko W ^a   Janssen, Harry L A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; PEGINTERFERON ALPHA2B; PLACEBO;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANALYTIC METHOD; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA VIRUS; FOLLOW UP; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION;

ADULT; ANTIVIRAL AGENTS; BIOPSY; DNA, VIRAL; DRUG CARRIERS; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON ALFA-2B; MALE; POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

EID: 33644882231     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00418.x     Document Type: Article

References (34)

1. Lai CL Ratziu V Yuen MF et al Viral hepatitis B Lancet 2003 362 9401 2089 94
2. Ganem D Prince AM Hepatitis B virus infection - Natural history and clinical consequences N Engl J Med 2004 350 11 1118 29
3. Lee WM Hepatitis B virus infection N Engl J Med 1997 337 24 1733 45
4. Yuen MF Wong DK Sablon E et al HBsAg seroclearance in chronic hepatitis B in the Chinese: Virological, histological, and clinical aspects Hepatology 2004 39 6 1694 701
5. Yang HI Lu SN Liaw YF et al Hepatitis B e antigen and the risk of hepatocellular carcinoma N Engl J Med 2002 347 3 168 74
6. Beasley RP Hepatitis B virus. The major etiology of hepatocellular carcinoma Cancer 1988 61 10 1942 56
7. Chen YC Sheen IS Chu CM et al Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection Gastroenterology 2002 123 4 1084 9
8. Lai CL Chien RN Leung NW et al A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group N Engl J Med 1998 339 2 61 8
9. Dienstag JL Schiff ER Wright TL et al Lamivudine as initial treatment for chronic hepatitis B in the United States N Engl J Med 1999 341 17 1256 63
10. Lau DT Khokhar MF Doo E et al Long-term therapy of chronic hepatitis B with lamivudine Hepatology 2000 32 4 Pt 1 828 34
11. Perrillo RP Lai CL Liaw YF et al Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B Hepatology 2002 36 1 186 94
12. Kato Y Nakao K Hamasaki K et al Spontaneous loss of hepatitis B surface antigen in chronic carriers, based on a long-term follow-up study in Goto Islands, Japan J Gastroenterol 2000 35 3 201 5
13. Fattovich G Giustina G Sanchez-Tapias J et al Delayed clearance of serum HBsAg in compensated cirrhosis B: Relation to interferon alpha therapy and disease prognosis. European Concerted Action on Viral Hepatitis (EUROHEP) Am J Gastroenterol 1998 93 6 896 900
14. Janssen HL Gerken G Carreno V et al Interferon alfa for chronic hepatitis B infection: Increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP) Hepatology 1999 30 1 238 43
15. Korenman J Baker B Waggoner J et al Long-term remission of chronic hepatitis B after alpha-interferon therapy Ann Intern Med 1991 114 8 629 34
16. Janssen HL van Zonneveld M Senturk H et al Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: A randomised trial Lancet 2005 365 9454 123 9
17. Pas SD Fries E De Man RA et al Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays J Clin Microbiol 2000 38 8 2897 901
18. Ishak K Baptista A Bianchi L et al Histological grading and staging of chronic hepatitis J Hepatol 1995 22 6 696 9
19. Bortolotti F Cadrobbi P Crivellaro C et al Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood Gastroenterology 1990 99 3 805 10
20. Shiffman M Marcellin P Jeffers L et al HBsAg seroconversion in Adefovir Dipivoxil (ADV) treated chronic hepatitis B (CHB) patients J Hepatol 2004 2004 17
21. Lau GK Piratvisuth T Luo KX et al Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B N Engl J Med 2005 352 26 2682 95
22. Maynard M Parvaz P Durantel S et al Sustained HBs seroconversion during lamivudine and adefovir dipivoxil combination therapy for lamivudine failure J Hepatol 2005 42 2 279 81
23. Guidotti LG Rochford R Chung J et al Viral clearance without destruction of infected cells during acute HBV infection Science 1999 284 5415 825 9
24. van Bommel F Wunsche T Mauss S et al Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection Hepatology 2004 40 6 1421 5
25. van Nunen AB Hansen BE Suh DJ et al Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: Relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase Gut 2003 52 3 420 4
26. van Zonneveld M Honkoop P Hansen BE et al Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B Hepatology 2004 39 3 804 10
27. Sanchez-Tapias JM Costa J Mas A et al Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients Gastroenterology 2002 123 6 1848 56
28. Erhardt A Reineke U Blondin D et al Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B Hepatology 2000 31 3 716 25
29. Chu CJ Lok AS Clinical significance of hepatitis B virus genotypes Hepatology 2002 35 5 1274 6
30. Chu CJ Hussain M Lok AS Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C Gastroenterology 2002 122 7 1756 62
31. Kao JH Wu NH Chen PJ et al Hepatitis B genotypes and the response to interferon therapy J Hepatol 2000 33 6 998 1002
32. Hou J Schilling R Janssen HLA et al Hepatitis B virus genotypes and response to interferon alpha treatment in chronic hepatitis B Hepatology 2001 34 4 447A
33. Marcellin P Lau GK Bonino F et al Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B N Engl J Med 2004 351 12 1206 17
34. Marcellin P Martinot-Peignoux M Loriot MA et al Persistence of hepatitis B virus DNA demonstrated by polymerase chain reaction in serum and liver after loss of HBsAg induced by antiviral therapy Ann Intern Med 1990 112 3 227 8